Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.990

+3.1%

11:33 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Keiko who wrote (7345)	11/5/1997 6:01:00 PM
From: Ace	Read Replies (1) of 14328

To All : Thumbs down on the split ... A bit of info from ISSN 0790 1747 Trinity Biotech has received a $600,000 marketing assistance package from the Irish Trade Board to help with the European launch of its Uni-Gold immunodiagnostic rapid tests. The funds will be made available over a 2 year period and will be repaid through a royalty on European sales commencing in the 3rd year of the program.. Future Uni-Gold products for Chlamydia and H. pylorii will be launched in the lst quarter of 1998 and a Strep. A product in the 2nd quarter. A prostate specific antigen product is due in the 3rd quarter while a test for Hepatitis A, in conjunction with Smithkline Beecham is due for the final quarter of 1998. Other products in the pipeline include tests for Hepatitis C, HIV and Influenza which Trinity hope to launch in 1999. According to company officials the market for its diagnostic products is currently worth $18 billion and growing rapidly.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next